1. Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials
- Author
-
Li-Qiang Qin, Guo-Chong Chen, Li-Hua Chen, Li Fan, Yu Feng, and Chun-ling Fu
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Ubiquinone ,Treatment duration ,Anti-Inflammatory Agents ,Patient characteristics ,Cochrane Library ,Bioinformatics ,Gastroenterology ,law.invention ,03 medical and health sciences ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Internal medicine ,Humans ,Medicine ,Randomized Controlled Trials as Topic ,Pharmacology ,Coenzyme Q10 ,biology ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,business.industry ,C-reactive protein ,Vitamins ,Confidence interval ,C-Reactive Protein ,030104 developmental biology ,chemistry ,Meta-analysis ,Dietary Supplements ,biology.protein ,business - Abstract
The aims of this meta-analysis were to evaluate the effects of coenzyme Q10 (CoQ10) supplementation on inflammatory mediators including C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) by analyzing published randomized controlled trials (RCTs). A systematic search in PubMed, Cochrane Library and Clinicaltrials.gov was performed to identify eligible RCTs. Data synthesis was performed using a random- or a fixed-effects model depending on the results of heterogeneity tests, and pooled data were displayed as weighed mean difference (WMD) and 95% confidence interval (CI). Seventeen RCTs were selected for the meta-analysis. CoQ10 supplementation significantly reduced the levels of circulating CRP (WMD: -0.35mg/L, 95% CI: -0.64 to -0.05, P=0.022), IL-6 (WMD: -1.61pg/mL, 95% CI: -2.64 to -0.58, P=0.002) and TNF-α (WMD: -0.49pg/mL, 95% CI: -0.93 to -0.06, P=0.027). The results of meta-regression showed that the changes of CRP were independent of baseline CRP, treatment duration, dosage, and patients characteristics. In the meta-regression analyses, a higher baseline IL-6 level was significantly associated with greater effects of CoQ10 on IL-6 levels (P for interaction=0.006). In conclusion, this meta-analysis of RCTs suggests significant lowering effects of CoQ10 on CRP, IL-6 and TNF-α. However, results should be interpreted with caution because of the evidence of heterogeneity and limited number of studies.
- Published
- 2017
- Full Text
- View/download PDF